Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer

Cancer Chemotherapy and Pharmacology

Volumn 46, Issue 3, 2000, Pages 180-184

  Sadahiro, S ^a   Ohki, S ^a   Yamaguchi, S ^a,a   Takahashi, T ^a   Otani, Y ^a   Tsukikawa, S ^a   Yamamura, T ^a   Takemiya, S ^a   Nagasaki, H ^a   Nishiyama, K ^a   Fukushima, T ^a   Hiki, Y ^a   Kumada, K ^a   Shimada, H ^a   Mitomi, T ^a   Makuuchi, H ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Adjuvant chemotherapy; Colorectal cancer; Compliance; UFT

Indexed keywords

UFT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COLORECTAL CANCER; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; LEUKOPENIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROTOXICITY; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SKIN TOXICITY; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; HUMAN; MALE; MIDDLE AGE; PATIENT COMPLIANCE; TEGAFUR; URACIL;

EID: 0033807408     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000146     Document Type: Article

References (23)

1. The description of chemotherapy delivery: Option and pitfalls
2. Oral chemotherapy: Rationale and future directions
3. Inter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells
4. Criteria for the evaluation of the clinical effects of solid cancer chemotherapy
5. Patient compliance with oral chemotherapy as assessed by a novel electronic technique
6. Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer
7. Patient compliance with prolonged oral altretamine treatment in relapsed ovarian cancer
8. Compliance with oral drug therapy in patients with hematologic malignancy
9. Patient preferences for oral versus intravenous palliative chemotherapy
10. Cooperative study of surgical adjuvant chemotherapy for colorectal cancer (fourth report): Five-year results after surgery
11. Individual dose intensity and relative performance as indices for assessing the quality of clinical cancer chemotherapy and their effect on therapeutic results
12. Adjuvant chemotherapy with MFC-related regimens for patients with gastric cancer after curative gastrectomy
13. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: A prospective randomized clinical trial
14. Usage of urine FT level for medication compliance in head and neck cancer patients with administration of UFT
15. A study of urinary tegafur, 5-fluorouracil and uracil concentrations in the case of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration
16. Adjuvant chemotherapy with mitomycin C, tegafur and UFT for colorectal cancer
17. Report on nationwide pooled data and cohort investigation in UFT phase II study
18. Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma
19. Preliminary study on the optimal dosage schedule for oral tegafur/uracil (UFT) chemotherapy
20. A meta-analysis of adjuvant therapy using oral fluoropyrimidines in patients with curatively resected colorectal carcinoma
21. A fixed-ratio combination of uracil and ftorafur (UFT) with low dose leucovorin
22. Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer
23. Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring